Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-26.44	98.68	134.14
Graham Fair Price	48.89	5226.51	3510.24
PEG	-99.96	0.33	-931.82
Price/Book	33.88	9.46	7.06
Price/Cash Flow	-55.42	-233.03	-149.93
Prices/Earnings	-34.97	37.31	57.38
Price/Sales	20.62	13.12	10.87
Price/FCF	-55.42	-233.03	-149.93
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	19.12	0.19	0.16
Operating Margin	89.02	0.12	0.06
ROA	105.90	0.03	0.01
ROE	0.03	0.06	105.88
ROIC	0.02	0.04	74.09
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.04	0.05	-23.66
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.20	1.18	496.57
EPS QOQ	< 0.005	1.14	184438.64
FCF QOQ	0.28	0.11	-62.17
Revenue QOQ	0.04	0.15	255.38
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	108.59	91.56	-15.68
Days Sales Outstanding (DSO)	80.82	86.82	7.43
Inventory Turnover	0.83	0.98	18.60
Debt/Capitalization	0.46	0.46	0.01
Quick Ratio	0.70	0.77	9.04
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	4218.08	4377.04	3.77
Cash	769.42	671.67	-12.70
Capex	-209.61	-178.24	14.97
Free Cash Flow	-198.76	-177.66	10.61
Revenue	2740.26	3156.08	15.17
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.32	1.31	-0.51
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	11.79	6.89	-41.60
Naive Interpretation	Member

06 - Financial Health · Weak

Rating